- Home
- PRTS vs TPST Comparison
PRTS vs TPST Comparison
Compare PRTS & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- TPST
- Stock Information
- Founded
- PRTS 1995
- TPST 2011
- Country
- PRTS United States
- TPST United States
- Employees
- PRTS N/A
- TPST N/A
- Industry
- PRTS Auto & Home Supply Stores
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- TPST Health Care
- Exchange
- PRTS Nasdaq
- TPST Nasdaq
- Market Cap
- PRTS 40.0M
- TPST 45.5M
- IPO Year
- PRTS 2007
- TPST N/A
- Fundamental
- Price
- PRTS $0.76
- TPST $9.92
- Analyst Decision
- PRTS Hold
- TPST Hold
- Analyst Count
- PRTS 1
- TPST 3
- Target Price
- PRTS $0.70
- TPST $30.00
- AVG Volume (30 Days)
- PRTS 1.4M
- TPST 60.6K
- Earning Date
- PRTS 10-28-2025
- TPST 11-11-2025
- Dividend Yield
- PRTS N/A
- TPST N/A
- EPS Growth
- PRTS N/A
- TPST N/A
- EPS
- PRTS N/A
- TPST N/A
- Revenue
- PRTS $577,614,000.00
- TPST N/A
- Revenue This Year
- PRTS N/A
- TPST N/A
- Revenue Next Year
- PRTS $2.62
- TPST N/A
- P/E Ratio
- PRTS N/A
- TPST N/A
- Revenue Growth
- PRTS N/A
- TPST N/A
- 52 Week Low
- PRTS $0.68
- TPST $5.35
- 52 Week High
- PRTS $1.42
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- PRTS 41.21
- TPST 51.47
- Support Level
- PRTS $0.84
- TPST $9.90
- Resistance Level
- PRTS $1.36
- TPST $11.02
- Average True Range (ATR)
- PRTS 0.12
- TPST 0.66
- MACD
- PRTS -0.02
- TPST -0.14
- Stochastic Oscillator
- PRTS 1.48
- TPST 22.34
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.